☆ 4.8 Article

Microneedle Patch Delivery of PROTACs for Anti-Cancer Therapy

ACS NANO (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Multidisciplinary

A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis-Targeting Chimeras Enhanced Immunotherapy

Yaping Wu et al.

Summary: An injectable nanocomposite hydrogel has been developed to suppress the growth and metastasis of head and neck squamous cell carcinoma. This hydrogel undergoes in situ gelation, degrades over time, and releases nanoparticles for both immunotherapy and chemotherapy, enhancing the efficacy of treatment.

ADVANCED MATERIALS (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Silk Microneedle Patch Capable of On-Demand Multidrug Delivery to the Brain for Glioblastoma Treatment

Zijing Wang et al.

Summary: A silk fibroin microneedle (SMN) patch designed for glioblastoma (GBM) can bypass the blood-brain barrier and release multiple drugs directly to the tumor site, providing an effective treatment strategy for brain tumors. The biocompatible and biodegradable patch allows for slow drug release over time and can be triggered remotely for rapid drug delivery. In animal models, the patch resulted in decreased tumor volume and increased survival rate, showing potential for clinical treatment of brain tumors.

ADVANCED MATERIALS (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Meeting Abstract Oncology

First-in-human safety and activity of ARV-471, a novel PROTAC (R) estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer

Erika Hamilton et al.

CANCER RESEARCH (2022)

添加到收藏夹

Article Engineering, Environmental

Bioinspired adhesive microneedle patch with gemcitabine encapsulation for pancreatic cancer treatment

Xiao Fu et al.

Summary: Inspired by the structures of octopus tentacles, researchers have developed a novel adhesive microneedle patch with gemcitabine encapsulation for the treatment of pancreatic cancer. The patch, made of gelatin methacryloyl, demonstrates good biocompatibility, flexibility, and drug loading efficiency. It can adhere to the irregular surfaces of tumors and efficiently release gemcitabine to penetrate tumor tissues, showing promising anti-tumor efficacy in vitro and in a mouse model.

CHEMICAL ENGINEERING JOURNAL (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy

Jing Gao et al.

Summary: Researchers have developed a new polymeric PROTAC nanoparticle for targeted delivery and degradation of proteins in tumors, combined with photodynamic therapy. This study demonstrates the potential of POLY-PROTACs for precise protein degradation and PROTAC-based cancer therapy.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Detachable Microneedle Patches Deliver Mesenchymal Stromal Cell Factor-Loaded Nanoparticles for Cardiac Repair

Shiqi Hu et al.

Summary: A detachable therapeutic microneedle patch has been developed to deliver mesenchymal stromal cell-secreted factors directly into the heart, showing promising potential for treatment.

ACS NANO (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

Adam D. Cotton et al.

Summary: AbTACs are fully recombinant bispecific antibodies that recruit membrane-bound E3 ligases for the degradation of cell-surface proteins. This new archetype represents a method within the PROTAC field to target cell-surface proteins with fully recombinant biological molecules.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

添加到收藏夹

Review Medicine, General & Internal

Breast cancer

Sibylle Loibl et al.

Summary: Breast cancer diagnosis and treatment have become increasingly complex, incorporating various biomarkers and neoadjuvant therapies, with de-escalation schemes for radiotherapy now becoming standard practice.

LANCET (2021)

添加到收藏夹

Review Chemistry, Multidisciplinary

From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation

Carlotta Cecchini et al.

Summary: PROTACs are heterobifunctional degraders that eliminate targeted proteins by utilizing the UPS system, showing potential as an appealing technology in drug discovery. However, their poor cellular permeability due to high molecular weight and large polar surface area poses challenges, requiring strategies and biological tools to enhance cellular uptake.

FRONTIERS IN CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Aptamer-PROTAC Conjugates (APCs) for Tumor-Specific Targeting in Breast Cancer

Shipeng He et al.

Summary: The aptamer-PROTAC conjugation strategy shows potential in improving the tumor-specific targeting ability and in vivo antitumor potency of conventional PROTACs, paving the way for the design of tumor-specific targeting PROTACs.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

添加到收藏夹

Article Biochemical Research Methods

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones

Tasuku Ishida et al.

Summary: PROTACs, or bifunctional degrader molecules, are a novel approach for understanding and treating human diseases by targeting specific proteins for degradation. Advances in nonpeptidic small-molecule E3 ligase ligands, such as VHL and CRBN, have revolutionized the field and led to the development of drug-like PROTACs with powerful degradation capabilities. Ongoing research aims to expand the chemical diversity of PROTACs and explore new approaches for targeted protein degradation.

SLAS DISCOVERY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity

Thomas H. Pillow et al.

CHEMMEDCHEM (2020)

添加到收藏夹

Article Chemistry, Medicinal

Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)

Peter S. Dragovich et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Proteolysis-targeting chimeras in drug development: A safety perspective

Kevin Moreau et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Light-induced control of protein destruction by opto-PROTAC

Jing Liu et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

PHOTACs enable optical control of protein degradation

Martin Reynders et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Non-invasive imaging of Young's modulus and Poisson's ratio in cancers in vivo

Md Tauhidul Islam et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Lysosome-targeting chimaeras for degradation of extracellular proteins

Steven M. Banik et al.

NATURE (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs

Li Qiao et al.

THERANOSTICS (2020)

添加到收藏夹

Article Nanoscience & Nanotechnology

Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness

Fei Peng et al.

NATURE NANOTECHNOLOGY (2019)

添加到收藏夹

Article Cell Biology

Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential

Tyler A. Allen et al.

JOURNAL OF CELL SCIENCE (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation

Drishti Rathod et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Light-Induced Protein Degradation with Photocaged PROTACs

Gang Xue et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)

Jiantao Hu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Article Medicine, General & Internal

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

N. C. Turner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Cardiac cell-integrated microneedle patch for treating myocardial infarction

Junnan Tang et al.

SCIENCE ADVANCES (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Induced protein degradation: an emerging drug discovery paradigm

Ashton C. Lai et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

添加到收藏夹

Review Oncology

Recent advances of highly selective CDK4/6 inhibitors in breast cancer

Hanxiao Xu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

Lesley-Ann Martin et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Cell Biology

Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein

Lynn A. Sheldon

CELL CYCLE (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin

Magdiel I. Setyawati et al.

ACS NANO (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Nanoparticle Density: A Critical Biophysical Regulator of Endothelial Permeability

Chor Yong Tay et al.

ACS NANO (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Proteolysis-Targeting Chimeras: Induced Protein Degradation as a Therapeutic Strategy

Philipp Ottis et al.

ACS CHEMICAL BIOLOGY (2017)

添加到收藏夹

Review Chemistry, Multidisciplinary

Small-Molecule PROTACS: New Approaches to Protein Degradation

Momar Toure et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer

Tommaso De Marchi et al.

DRUG DISCOVERY TODAY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway

Xing-Hua Liao et al.

FEBS JOURNAL (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin

M. I. Setyawati et al.

NATURE COMMUNICATIONS (2013)

添加到收藏夹

Article Medicine, General & Internal

Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer

Rita S. Mehta et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

添加到收藏夹

Article Oncology

Incidence of Breast Cancer in the United States: Current and Future Trends

William F. Anderson et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Impact of linker length on the activity of PROTACs

Kedra Cyrus et al.

MOLECULAR BIOSYSTEMS (2011)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Development of subtype-selective oestrogen receptor-based therapeutics

Stefan Nilsson et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

添加到收藏夹

Article Chemistry, Multidisciplinary

Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (β-amino ester) block copolymer micelles for cancer therapy

Jinyoung Ko et al.

JOURNAL OF CONTROLLED RELEASE (2007)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance

JS Lewis et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)

添加到收藏夹

Article Multidisciplinary Sciences

Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation

KM Sakamoto et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.